Were you injured using any of these medications?
Invokana | Invokamet | Farxiga | Jardiance | Xigduo XR | Glyxambi
If you took Invokana, Invokamet, Farxiga, Jardiance, Xigduo XR or Glyxambi and suffered diabetic ketoacidosis, kidney failure or other side effects as a result, you may be entitled to financial compensation. Fill out the claim review form to speak to an experienced lawyer today.
- Diabetic ketoacidosis (DKA)
- Ketoacidosis
- Acidosis
- Diabetic coma
- Heart attack
- Stroke
- Kidney failure
- Cardiovascular problems
- Wrongful death
- Breathing difficulty
- Vomiting
- Abdominal pain
- Confusion
- Frequent urination
- Elevated levels ketones in urine
- Excessive thirst
- Unusual fatigue or sleepiness
Lawsuits Allege That These Side Effects Are Linked to the Type 2 Diabetes Drug Invokana.
According to a recent warning issued by the U.S. Food and Drug Administration (FDA), adults with Type 2 diabetes who take the sodium-glucose co-transporter 2 (SGLT2) inhibitor Invokana, may be at risk for diabetic ketoacidosis, diabetic coma and other serious side effects. Among the severe complications allegedly linked to Invokana treatment are:
- Diabetic ketoacidosis (DKA)
- Ketoacidosis
- Acidosis
- Diabetic coma
- Heart attack
- Stroke
- Kidney failure
- Cardiovascular problems
- Wrongful death
If you believe you have been adversely affected by side effects of Invokana, fill out the case review form today to discuss your drug injury claim with an experienced Invokana attorney.
Side Effects Potentially Linked to Invokana
Since the prescription drug Invokana (canagliflozin) first garnered approval from the FDA in March 2013, it has been aggressively marketed by Johnson Johnson and its Janssen Pharmaceuticals subsidiary as a safe and effective way to help control blood sugar levels in adults diagnosed with Type 2 diabetes. However, even as more and more Type 2 diabetes patients use Invokana and other products in the SGLT2 inhibitor class of drugs, the FDA and other regulatory agencies have issued alarming warnings regarding the potential adverse effects associated with the prescription medications, which may include diabetic ketoacidosis (DKA), diabetic coma and death.
According to a drug safety communication issued by the FDA in May 2015, there were 20 reports of acidosis identified as diabetic ketoacidosis, ketoacidosis or acidosis submitted to the agency’s Adverse Event Reporting System involving the use of SGLT2 inhibitors like Invokana between March 2013 and June 6, 2014. That same month, the Institute for Safe Medication Practices (ISMP) released its own independent report based on drug complications reported to the FDA, and found 457 serious adverse events involving side effects of Invokana. If you took Invokana in the past, and you have suffered a major medical event as a result, contact a reputable Invokana lawyer today for legal help.
Contact a Reputable Invokana Lawyer for Help
As concerns continue to mount over the potential side effects of Invokana and other popular SGLT2 inhibitor drugs, like Invokamet (canagliflozin/metformin), Glyxambi (empagliflozin/linagliptin), Farxiga (dapagliflozin), Xigduo XR (dapagliflozin/metformin) and Jardiance (empagliflozin), drug injury claims are expected to be brought against Janssen Pharmaceuticals and other manufacturing companies, on behalf of consumers who used the medications and have since suffered diabetic ketoacidosis and other potentially life-threatening side effects. If you have been diagnosed with DKA, kidney failure, heart attack, or another major medical event, you may be entitled to financial compensation for your injuries, medical expenses, and pain and suffering. Fill out the case review form now to speak to a knowledgeable Invokana lawyer about your drug injury claim.
Start Claim Now